Imunoterapi Dokter Terbaik di Israel - TOP-20 dokter

Prof. Merimsky memimpin penelitian imunoterapi di Pusat Medis Sourasky, dengan keahlian puluhan tahun dalam pengobatan kanker tingkat lanjut.

• Kepala Unit Onkologi Jaringan Lunak dan Tulang
• Anggota fakultas di kelompok Sarkoma European Society of Medical Oncology (ESMO)
• Kolaborasi penelitian yang luas dengan Weizmann Institute dan Felsenstein Medical Research Center
• Pengalaman lebih dari 20 tahun dalam praktik onkologi klinis

Dr. Pelles Sharon berspesialisasi dalam imunoterapi, termasuk perawatan seperti Keytruda, di Sourasky Medical Center (Ichilov).

• Berpengalaman dalam berbagai perawatan kanker dengan fokus pada imunoterapi
• Berkontribusi pada penelitian klinis tentang sikap pasien onkologi terhadap uji coba
• Melakukan prosedur lanjutan seperti Kemoterapi Intraperitoneal Hipertermik (HIPEC)
• Menawarkan terapi yang ditargetkan di samping perawatan kanker tradisional

Dr. Sarid, seorang onkolog senior di Ichilov, berspesialisasi dalam terapi kanker biologis dengan lebih dari 30 artikel yang diterbitkan mengenai pengobatan kanker.

• Lebih dari 15 tahun sebagai onkolog senior di Sourasky Medical Center
• Peneliti utama dalam uji klinis untuk terapi kanker
• Pelatihan spesialisasi dalam urologi kanker dari Universitas Oxford
• Anggota ESMO dan ASCO – organisasi onkologi terkemuka

Spesialis Ginekologi Onkologi dan Radioterapi – Dr. Sapra membawa keahlian terfokus pada kasus imunoterapi di Sourasky Medical Center.

• Berspesialisasi dalam perawatan onkologi ginekologi
• Keahlian dalam aplikasi radioterapi
• Praktik di pusat medis terkemuka di Israel

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Ido Wolf memimpin Divisi Onkologi Medis di Sourasky Medical Center, berspesialisasi dalam imunoterapi.

• Kepala Divisi Onkologi Medis di Sourasky Medical Center
• Gelar dari Ben Gurion University of the Negev
• Pengalaman dalam Onkologi, Penyakit Dalam, dan Unit Medis Angkatan Darat

Memimpin uji coba imunoterapi di Sourasky Medical Center – Dr. Raphael berspesialisasi dalam profil genomik dan injeksi intra-tumoral untuk kanker toraks.

• Peneliti utama untuk berbagai uji klinis imunoterapi, termasuk studi pembrolizumab
• Ahli dalam biopsi cair dan sekuensing repertoar sel-T untuk respons pengobatan
• Moderator Molecular Tumor Board untuk Perkumpulan Kanker Paru Israel
• Dianugerahi sebagai Pengajar Luar Biasa di fakultas kedokteran Universitas Tel-Aviv
• Pelatihan fellowship dalam Inovasi dan Kewirausahaan di bidang Kedokteran dan Teknologi Kesehatan

Direktur Layanan Neuro-onkologi dengan spesialisasi tumor otak selama lebih dari 25 tahun. Dr. Blumenthal memimpin program imunoterapi di Pusat Medis Sourasky.

• Pelatihan di Memorial Sloan-Kettering Cancer Center
• Mantan direktur di Huntsman Cancer Institute
• Berspesialisasi dalam perawatan neuro-onkologi tingkat lanjut

Direktur Rawat Inap Onkologi di Pusat Medis Tel Aviv – Dr. Stepfansky memimpin penelitian dan pengobatan imunoterapi di Ichilov.

• Lebih dari 15 tahun berspesialisasi dalam onkologi
• Peneliti utama dalam uji klinis fase 1–3
• Pelatihan di Pusat Medis Tel Aviv
• Ahli dalam penyakit dalam dan onkologi

Dr. Fredi Aviv memiliki 31 tahun pengalaman khusus dalam onkohematologi di Sourasky Medical Center (Klinik Ichilov).

• Berspesialisasi dalam pengobatan imunoterapi untuk kanker darah
• Pengalaman luas dengan keganasan hematologi yang kompleks
• Praktik di salah satu pusat medis terkemuka di Israel

Dr. Dror Levin adalah pakar terkemuka dalam hematologi onkologi pediatrik, berspesialisasi dalam pengobatan kanker tulang (sarkoma) untuk anak-anak di Pusat Medis Sourasky di Tel Aviv.

• Direktur departemen hematologi onkologi anak di Pusat Medis Sourasky
• Berspesialisasi dalam hematologi dan onkologi pediatrik di Pusat Medis Anak Schneider
• Anggota asosiasi hemato-onkologi pediatrik Israel (ISPHO)
• Pelatihan dalam onkologi tulang dan jaringan lunak di Institut Ortopedi Rizzoli di Italia

Dr. Amir berspesialisasi dalam terapi tertarget dengan Keytruda (Pembolizumab) untuk kanker payudara, dengan lebih dari 30 presentasi pada pertemuan ilmiah.

• Penerima berbagai penghargaan, termasuk ESMO Breast Cancer Translational Research Award
• Anggota European Society of Medical Oncology (ESMO)
• Fellowship (Program Spesialisasi) dalam Penelitian Kanker Payudara di Emory University
• Lebih dari 15 tahun pengalaman di bidang onkologi

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Prof. Myriam Ben Arush adalah spesialis yang diakui secara internasional dalam onkologi pediatri dan transplantasi sumsum tulang di Rambam Medical Center.

• Direktur Divisi Pediatri di Rumah Sakit Anak Ruth Rappaport
• Penerima penghargaan Chevalier de la Legion d'Honneur di Prancis
• Dinobatkan sebagai salah satu dokter yang paling peduli di dunia oleh Asosiasi Medis Dunia
• Anggota Children's Oncology Group di AS

Berspesialisasi dalam radioterapi dan onkologi, Dr. Karen Drumea membawa keahlian terfokus pada imunoterapi di Rambam Medical Center.

• Spesialis radioterapi dengan pelatihan onkologi
• Bekerja di Rambam Medical Center
• Berfokus pada integrasi radioterapi dengan imunoterapi

Kepala Dokter Pusat Onkologi di Assuta Medical Center, Dr. Tepper berspesialisasi dalam perawatan imunoterapi.

• Bertahun-tahun pengalaman dalam onkologi dengan fokus pada terapi inovatif
• Memimpin tim khusus untuk rencana perawatan yang dipersonalisasi
• Terlibat aktif dalam memajukan protokol imunoterapi

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.